Is Pharma Building the Right Facilities for Future Biologics? - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Is Pharma Building the Right Facilities for Future Biologics?

As biologics portfolios expand and average product volumes fall, Miriam Monge asks whether today’s major manufacturing investments offer the flexibility tomorrow’s market will require

  • By

  • Miriam Monge

  • November 9, 2026

  • 5 min

Share

Original Source(s)

Is Pharma Building the Right Facilities for Future Biologics?

  • by Miriam Monge

  • November 9, 2026

Related Content

Two ‘forever chemicals’ associated with higher risk of aggressive breast cancer in NIH analysis

  • November 5, 2026

4 societies align on 2026–2027 respiratory vaccine guidance

New guidance addresses COVID-19, influenza, and RSV across age and risk groups.

Durability of Immunity and Safety of RSV Vaccination in High-Risk Transplant Recipients